This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brandi ML et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671
Machens A et al. (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349: 1517–1525
Modigliani E et al. (1998) Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'Etude des Tumeurs a Calcitonine. Clin Endocrinol (Oxf) 48: 265–273
Scollo C et al. (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88: 2070–2075
Machens A et al. (2005) Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90: 2029–2034
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Baudin, E., Paul Travagli, J. & Schlumberger, M. How effective is prophylactic thyroidectomy in asymptomatic multiple endocrine neoplasia type 2A?. Nat Rev Endocrinol 2, 256–257 (2006). https://doi.org/10.1038/ncpendmet0170
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0170